Natixis’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-69,030
| Closed | -$2.12M | – | 1071 |
|
|
2022
Q3 | $2.12M | Hold |
69,030
| – | – | 0.01% | 566 |
|
|
2022
Q2 | $2.03M | Sell |
69,030
-167,658
| -71% | -$4.94M | 0.01% | 628 |
|
|
2022
Q1 | $7.61M | Sell |
236,688
-56,866
| -19% | -$1.83M | 0.03% | 454 |
|
|
2021
Q4 | $13.1M | Buy |
293,554
+14,300
| +5% | +$638K | 0.04% | 326 |
|
|
2021
Q3 | $14.1M | Buy |
279,254
+69,556
| +33% | +$3.51M | 0.05% | 295 |
|
|
2021
Q2 | $16.4M | Buy |
209,698
+70,000
| +50% | +$5.49M | 0.07% | 215 |
|
|
2021
Q1 | $7.98M | Sell |
139,698
-151,000
| -52% | -$8.62M | 0.03% | 417 |
|
|
2020
Q4 | $24.3M | Buy |
290,698
+264,710
| +1,019% | +$22.2M | 0.09% | 227 |
|
|
2020
Q3 | $931K | Buy |
+25,988
| New | +$931K | 0.01% | 535 |
|